講演情報
[EPD1-1]Indications and Pitfalls of Conversion Surgery for Esophageal and Esophagogastric Junction Cancer
Zhigang Li (Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, China)
Zhigang Li, M.D., Ph.D., is the chief of Division of Thoracic Surgery and the director of Esophageal Surgery Section at Shanghai Chest Hospital.
1997 Graduated from The Second Military Medical University（MB, equivalent to MD）
2002 Obtained Ph.D. from Second Military Medical University
2002–2013 Assistant Professor & Cardiothoracic Surgeon, Changhai Hospital, SMMU
2011–2012 Evarts A. Graham Memorial Travelling Fellow（AATS）, Cleveland Clinic, USA
2014–2024 Attending Surgeon, Deputy Chief of Thoracic Surgery & Section Head of Esophageal Surgery, Shanghai Chest Hospital
2024–present Attending Surgeon, Chief of Thoracic Surgery & Section Head of Esophageal Surgery, Shanghai Chest Hospital
After completing "The Evarts A. Graham Memorial Traveling Fellowship" training program in the United States, he established the Esophageal Surgery Section in Shanghai Chest Hospital in 2015, and has make it to be the largest program in the world. He is also dedicated to the minimally invasive surgical treatment of esophageal diseases and established the world's largest robotic assisted esophagectomy program. As a surgeon with wide range of academic interests, he also pioneered the development of Chinese magnetic sphincter augmentation（MSA）for GERD treatment in China. At the same time, he is committed to a large number of clinical studies, such as PreSINO, RAMIE, AdESD, and NICE trial.
1997 Graduated from The Second Military Medical University（MB, equivalent to MD）
2002 Obtained Ph.D. from Second Military Medical University
2002–2013 Assistant Professor & Cardiothoracic Surgeon, Changhai Hospital, SMMU
2011–2012 Evarts A. Graham Memorial Travelling Fellow（AATS）, Cleveland Clinic, USA
2014–2024 Attending Surgeon, Deputy Chief of Thoracic Surgery & Section Head of Esophageal Surgery, Shanghai Chest Hospital
2024–present Attending Surgeon, Chief of Thoracic Surgery & Section Head of Esophageal Surgery, Shanghai Chest Hospital
After completing "The Evarts A. Graham Memorial Traveling Fellowship" training program in the United States, he established the Esophageal Surgery Section in Shanghai Chest Hospital in 2015, and has make it to be the largest program in the world. He is also dedicated to the minimally invasive surgical treatment of esophageal diseases and established the world's largest robotic assisted esophagectomy program. As a surgeon with wide range of academic interests, he also pioneered the development of Chinese magnetic sphincter augmentation（MSA）for GERD treatment in China. At the same time, he is committed to a large number of clinical studies, such as PreSINO, RAMIE, AdESD, and NICE trial.